Daichii Sankyo concludes Ranbaxy Deal

Published as Comment in : economictimes.com dated 08.11.08
Ranbaxy which has been battered not only at the Stock Exchanges ,but also had to bear the brunt of FDA USA, which had banned import of drugs manufactured by Ranbaxy at two plants in India ,infact, has effected its earnings , and Ranbaxy had a huge inventory ,and it had to write off about Rs.395 Crores ,in its book of accounts and has reported a huge loss in Quarter 3, and has forecasted that losses shall be effected in Quarter 4 also. Now that the deal has been clinched by Daichii Sankyo Japan and the deal between Ranbaxy and Daichii Sankyo has finally concluded. It is only hoped that speculation regarding the company shall die a natural death and its stock shall not take a beating at the stock market and it shall again be back to the roads of growth and keep the flag of Ranbaxy Daichii Sankyo flying not only in India, Japan but also the world over through presentation of innovative drugs, molecules, research.Best of Luck.